GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Trinity Biotech PLC (NAS:TRIB) » Definitions » Dividend Payout Ratio

TRIB (Trinity Biotech) Dividend Payout Ratio : 0.00 (As of Sep. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Trinity Biotech Dividend Payout Ratio?

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Trinity Biotech's Dividend Payout Ratio for the months ended in Sep. 2024 was 0.00.

The historical rank and industry rank for Trinity Biotech's Dividend Payout Ratio or its related term are showing as below:


During the past 13 years, the highest Dividend Payout Ratio of Trinity Biotech was 0.46. The lowest was 0.34. And the median was 0.40.

TRIB's Dividend Payout Ratio is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 0.415
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2025-03-16), the Dividend Yield % of Trinity Biotech is 0.00%.

During the past 13 years, the highest Trailing Annual Dividend Yield of Trinity Biotech was 2.33%. The lowest was 1.13%. And the median was 1.84%.

Trinity Biotech's Dividends per Share for the months ended in Sep. 2024 was $0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Trinity Biotech was 30.10% per year. The lowest was 13.60% per year. And the median was 21.85% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.


Trinity Biotech Dividend Payout Ratio Historical Data

The historical data trend for Trinity Biotech's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trinity Biotech Dividend Payout Ratio Chart

Trinity Biotech Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividend Payout Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Trinity Biotech Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Dividend Payout Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Trinity Biotech's Dividend Payout Ratio

For the Medical Devices subindustry, Trinity Biotech's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trinity Biotech's Dividend Payout Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Trinity Biotech's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Trinity Biotech's Dividend Payout Ratio falls into.



Trinity Biotech Dividend Payout Ratio Calculation

The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.

Trinity Biotech's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (A: Dec. 2023 )/ EPS without NRI (A: Dec. 2023 )
=0/ -3.453
=N/A

Trinity Biotech's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=0/ -0.426
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Trinity Biotech (NAS:TRIB) Dividend Payout Ratio Explanation

In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.


Trinity Biotech Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Trinity Biotech's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Trinity Biotech Business Description

Traded in Other Exchanges
N/A
Address
IDA Business Park, Bray, County Wicklow, Dublin, IRL, A98 H5C8
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.